JP2017209114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017209114A5 JP2017209114A5 JP2017168662A JP2017168662A JP2017209114A5 JP 2017209114 A5 JP2017209114 A5 JP 2017209114A5 JP 2017168662 A JP2017168662 A JP 2017168662A JP 2017168662 A JP2017168662 A JP 2017168662A JP 2017209114 A5 JP2017209114 A5 JP 2017209114A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81937806P | 2006-07-10 | 2006-07-10 | |
| US60/819,378 | 2006-07-10 | ||
| US89990707P | 2007-02-06 | 2007-02-06 | |
| US60/899,907 | 2007-02-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014123202A Division JP6226824B2 (ja) | 2006-07-10 | 2014-06-16 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019017744A Division JP2019089809A (ja) | 2006-07-10 | 2019-02-04 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017209114A JP2017209114A (ja) | 2017-11-30 |
| JP2017209114A5 true JP2017209114A5 (ja) | 2018-04-26 |
Family
ID=38792084
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009518698A Withdrawn JP2009542232A (ja) | 2006-07-10 | 2007-07-10 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2014123202A Active JP6226824B2 (ja) | 2006-07-10 | 2014-06-16 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2014123201A Active JP6230195B2 (ja) | 2006-07-10 | 2014-06-16 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2015248371A Pending JP2016041758A (ja) | 2006-07-10 | 2015-12-21 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2017168662A Pending JP2017209114A (ja) | 2006-07-10 | 2017-09-01 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2019017744A Withdrawn JP2019089809A (ja) | 2006-07-10 | 2019-02-04 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009518698A Withdrawn JP2009542232A (ja) | 2006-07-10 | 2007-07-10 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2014123202A Active JP6226824B2 (ja) | 2006-07-10 | 2014-06-16 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2014123201A Active JP6230195B2 (ja) | 2006-07-10 | 2014-06-16 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| JP2015248371A Pending JP2016041758A (ja) | 2006-07-10 | 2015-12-21 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019017744A Withdrawn JP2019089809A (ja) | 2006-07-10 | 2019-02-04 | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8936785B2 (ja) |
| EP (2) | EP3093026B1 (ja) |
| JP (6) | JP2009542232A (ja) |
| CN (2) | CN103251947B (ja) |
| AU (1) | AU2007272224B2 (ja) |
| CA (1) | CA2658241C (ja) |
| DK (1) | DK2046382T3 (ja) |
| ES (2) | ES2603399T3 (ja) |
| HU (1) | HUE032654T2 (ja) |
| LT (1) | LT2046382T (ja) |
| NZ (2) | NZ700275A (ja) |
| PL (1) | PL2046382T3 (ja) |
| PT (1) | PT2046382T (ja) |
| RU (3) | RU2438708C2 (ja) |
| SI (1) | SI2046382T1 (ja) |
| WO (1) | WO2008006235A2 (ja) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| US9241918B2 (en) | 2005-03-16 | 2016-01-26 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| JP2009542232A (ja) | 2006-07-10 | 2009-12-03 | エスバテック・アーゲー | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
| NZ579594A (en) * | 2007-03-12 | 2012-03-30 | Esbatech Alcon Biomed Res Unit | Sequence based engineering and optimization of single chain antibodies |
| CA2689941C (en) | 2007-06-25 | 2019-10-29 | Esbatech Ag | Methods of modifying antibodies, and modified antibodies with improved functional properties |
| DK2164961T3 (en) | 2007-06-25 | 2015-03-02 | Esbatech Alcon Biomed Res Unit | Sequence based forward position and optimization of single chain antibodies |
| WO2009033309A1 (en) | 2007-09-13 | 2009-03-19 | Esbatech Ag | HUMANIZED ANTIBODIES AGAINST THE ß-AMYLOYD PEPTIDE |
| WO2009097704A1 (en) * | 2008-02-05 | 2009-08-13 | Esbatech Ag | Antigen-binding polypeptides against cartilage degeneration |
| JP2009294202A (ja) * | 2008-05-09 | 2009-12-17 | Pola Chem Ind Inc | タイトジャンクションの物質輸送への関与の鑑別法 |
| CA2728829C (en) | 2008-06-25 | 2018-01-02 | Esbatech, An Alcon Biomedical Research Unit Llc | Solubility optimization of immunobinders |
| ES2687259T5 (es) | 2008-06-25 | 2022-10-14 | Novartis Ag | Anticuerpos estables y solubles que inhiben TNF |
| CA2728004C (en) | 2008-06-25 | 2022-05-24 | Esbatech, An Alcon Biomedical Research Unit Llc | Humanization of rabbit antibodies using a universal antibody framework |
| CN102164958A (zh) * | 2008-06-25 | 2011-08-24 | 艾斯巴技术,爱尔康生物医药研究装置有限责任公司 | 使用通用抗体构架进行的兔抗体的人源化 |
| US8349322B2 (en) | 2008-06-25 | 2013-01-08 | ESBATech, an Alcon Biomedical Research Unit, LLC | Stable and soluble antibodies inhibiting VEGF |
| CA2729185A1 (en) | 2008-06-30 | 2010-01-21 | Esbatech, An Alcon Biomedical Research Unit Llc | Methods and compositions for modifying immunobinders |
| CN104800147A (zh) * | 2008-07-10 | 2015-07-29 | 德勒尼克斯治疗股份公司 | 用于大分子的增强的递送的方法和组合物 |
| EP3181583A1 (en) | 2009-02-24 | 2017-06-21 | ESBATech, an Alcon Biomedical Research Unit LLC | Methods for identifying immunobinders of antigens |
| EP2443150B1 (en) * | 2009-06-17 | 2015-01-21 | AbbVie Biotherapeutics Inc. | Anti-vegf antibodies and their uses |
| US8399624B1 (en) | 2009-06-25 | 2013-03-19 | Esbatech, An Alcon Biomedical Research Unit Llc | Acceptor framework for CDR grafting |
| US9522153B2 (en) | 2009-12-22 | 2016-12-20 | Allergan, Inc. | Compositions and methods for lowering intraocular pressure |
| UY33679A (es) | 2010-10-22 | 2012-03-30 | Esbatech | Anticuerpos estables y solubles |
| US20140154255A1 (en) | 2012-11-30 | 2014-06-05 | Abbvie Biotherapeutics Inc. | Anti-vegf antibodies and their uses |
| US11079613B2 (en) * | 2013-03-05 | 2021-08-03 | EyeYon Medical Ltd. | Contact lens drug depot |
| WO2015086830A1 (en) * | 2013-12-13 | 2015-06-18 | Delenex Therapeutics Ag | Skin penetrating polypeptides |
| PT3167065T (pt) * | 2014-07-09 | 2020-07-01 | Lupin Ltd | Sistema de expressão bacteriana dual cistrónica |
| US11207410B2 (en) | 2015-07-21 | 2021-12-28 | Avedro, Inc. | Systems and methods for treatments of an eye with a photosensitizer |
| ES2843558T3 (es) * | 2015-08-17 | 2021-07-19 | Lupin Ltd | Proceso de replegamiento mejorado de fragmentos de anticuerpo |
| US11269987B2 (en) | 2019-09-09 | 2022-03-08 | International Business Machines Corporation | Security credentials management for client applications |
| WO2024058730A1 (en) | 2022-09-15 | 2024-03-21 | Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi | Stable and potent anti-angiogenic scfv fragments and uses as vegf antagonist thereof |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2433A (en) * | 1842-01-24 | Improvement in the construction of apparatus for condensing air to be | ||
| US2434A (en) * | 1842-01-24 | Improvement in the mode of propelling boats by means of endless chains of paddles | ||
| US4131648A (en) * | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
| US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
| US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
| US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
| US4946931A (en) | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
| US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US5968543A (en) * | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
| EP1140170B1 (en) | 1999-01-05 | 2006-06-21 | The Flinders University Of South Australia | Antibody fragments for the topical treatment of ocular diseases |
| AU6526100A (en) * | 1999-08-06 | 2001-03-05 | Board Of Regents, The University Of Texas System | Drug releasing biodegradable fiber implant |
| EP1242457B1 (en) * | 1999-12-28 | 2004-08-11 | Esbatech AG | Intrabodies with defined framework that is stable in a reducing environment and applications thereof |
| US6613355B2 (en) * | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| US6524606B1 (en) * | 2001-11-16 | 2003-02-25 | Ap Pharma, Inc. | Bioerodible polyorthoesters containing amine groups |
| US20030165545A1 (en) * | 2002-01-30 | 2003-09-04 | Allergan, Inc. | Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same |
| CA2379661A1 (en) | 2002-03-28 | 2003-09-28 | Kursad Turksen | Paracellular drug delivery system |
| ES2399617T3 (es) * | 2002-05-22 | 2013-04-02 | Esbatech - A Novartis Company Llc | Regiones de marco de inmunoglobulina que demuestran estabilidad potenciada en el entorno intracelulcar y métodos de identificación de las mismas |
| EP1651266B1 (en) * | 2003-07-25 | 2010-03-03 | Laboratorios Silanes, S.A. de C.V. | Administration of anti-tnf-alpha f(ab')2 antibody fragments |
| CA2557724A1 (en) | 2004-02-27 | 2005-10-06 | Centocor, Inc. | Methods and compositions for treating il-13 related pathologies |
| US20060062758A1 (en) | 2004-09-21 | 2006-03-23 | Nastech Pharmaceutical Comapny Inc. | Tight junction modulator peptide PN159 for enhanced mucosal delivery of therapeutic compounds |
| US20070160606A1 (en) | 2004-09-30 | 2007-07-12 | Heavner George A | Treating renal cell carcinoma with an anti-TNF human antibody or fragment |
| US7431927B2 (en) * | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
| US20080044420A1 (en) | 2005-05-11 | 2008-02-21 | Heavner George A | Anti-IL-13 antibodies, compositions, methods and uses |
| WO2006131013A2 (en) * | 2005-06-07 | 2006-12-14 | Esbatech Ag | STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| US20070141092A1 (en) * | 2005-12-21 | 2007-06-21 | Erning Xia | Biguanide composition and method of treatment and prevention of viral infections |
| US20070178103A1 (en) * | 2006-01-30 | 2007-08-02 | Fey Georg H | CD19-specific immunotoxin and treatment method |
| JP2009542232A (ja) | 2006-07-10 | 2009-12-03 | エスバテック・アーゲー | 上皮および／または内皮層を通過するｓｃＦｖ抗体 |
-
2007
- 2007-07-10 JP JP2009518698A patent/JP2009542232A/ja not_active Withdrawn
- 2007-07-10 WO PCT/CH2007/000334 patent/WO2008006235A2/en active Application Filing
- 2007-07-10 NZ NZ700275A patent/NZ700275A/en not_active IP Right Cessation
- 2007-07-10 ES ES07763939.1T patent/ES2603399T3/es active Active
- 2007-07-10 AU AU2007272224A patent/AU2007272224B2/en active Active
- 2007-07-10 NZ NZ574308A patent/NZ574308A/en not_active IP Right Cessation
- 2007-07-10 ES ES16175728T patent/ES2820837T3/es active Active
- 2007-07-10 CN CN201310159387.0A patent/CN103251947B/zh active Active
- 2007-07-10 EP EP16175728.1A patent/EP3093026B1/en active Active
- 2007-07-10 HU HUE07763939A patent/HUE032654T2/en unknown
- 2007-07-10 LT LTEP07763939.1T patent/LT2046382T/lt unknown
- 2007-07-10 RU RU2009104318/15A patent/RU2438708C2/ru active
- 2007-07-10 PL PL07763939T patent/PL2046382T3/pl unknown
- 2007-07-10 PT PT77639391T patent/PT2046382T/pt unknown
- 2007-07-10 CA CA2658241A patent/CA2658241C/en active Active
- 2007-07-10 DK DK07763939.1T patent/DK2046382T3/en active
- 2007-07-10 CN CN2007800314717A patent/CN101505794B/zh active Active
- 2007-07-10 SI SI200731858A patent/SI2046382T1/sl unknown
- 2007-07-10 US US12/307,875 patent/US8936785B2/en active Active
- 2007-07-10 EP EP07763939.1A patent/EP2046382B1/en active Active
-
2011
- 2011-06-24 RU RU2011126239/15A patent/RU2565399C2/ru active
-
2014
- 2014-04-30 US US14/266,444 patent/US20140234315A1/en not_active Abandoned
- 2014-06-16 JP JP2014123202A patent/JP6226824B2/ja active Active
- 2014-06-16 JP JP2014123201A patent/JP6230195B2/ja active Active
-
2015
- 2015-07-21 RU RU2015130221A patent/RU2015130221A/ru not_active Application Discontinuation
- 2015-12-21 JP JP2015248371A patent/JP2016041758A/ja active Pending
-
2017
- 2017-09-01 JP JP2017168662A patent/JP2017209114A/ja active Pending
-
2019
- 2019-02-04 JP JP2019017744A patent/JP2019089809A/ja not_active Withdrawn